LHRH analog treatment of central precocious puberty complicating congenital adrenal hyperplasia.
D000312:Adrenal Hyperplasia, Congenital / Q000150:complications* / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D003692:Delayed-Action Preparations; D005260:Female; D005438:Fludrocortisone / Q000627:therapeutic use*; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use*; D008297:Male; D011629:Puberty, Precocious / Q000188:drug therapy* / Q000209:etiology; D013250:Steroid Hydroxylases / Q000172:deficiency*; D017329:Triptorelin Pamoate / Q000031:analogs & derivatives*
D003692:Delayed-Action Preparations; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone; C019176:Tryptal; D013250:Steroid Hydroxylases; D005438:Fludrocortisone; D006854:Hydrocortisone